ImaBiotech SAS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:ImaBiotech SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10626
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ImaBiotech SAS (ImaBiotech) is a contract research organization that offers mass spectrometry imaging services. The organization’s software products include quantinetix and multimaging. It offers services such as biomarker discovery, consulting and training, screening studies, target engagement studies, pharmaco-kinetics and dynamics studies, MALDI imaging services and toxicology studies. ImaBiotech provides its MALDI imaging services to therapeutic areas such as central nervous system, dermatology and cosmetics, cardiovascular and metabolic diseases, gastroenterology and others. The organization’s consultancy and training services include cost and profitability, feasibility or protocol studies, MALDI imaging mass spectrometry platform installation, project design, data storage, instrumentation and IT and others. It has its operations in France and the US. ImaBiotech is headquartered in Loos, France.

ImaBiotech SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ImaBiotech SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ImaBiotech SAS, Medical Devices Deals, 2012 to YTD 2018 9
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
ImaBiotech Raises US$1.37 Million In Venture Financing 11
Partnerships 12
ImaBiotech Enters into Agreement with Dermira 12
Galderma Enters into Agreement with ImaBiotech 13
ImaBiotech Enters Into Agreement With Genfit 14
ImaBiotech SAS – Key Competitors 15
ImaBiotech SAS – Key Employees 16
ImaBiotech SAS – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
ImaBiotech SAS, Pharmaceuticals & Healthcare, Key Facts 2
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ImaBiotech SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ImaBiotech SAS, Deals By Therapy Area, 2012 to YTD 2018 8
ImaBiotech SAS, Medical Devices Deals, 2012 to YTD 2018 9
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ImaBiotech Raises US$1.37 Million In Venture Financing 11
ImaBiotech Enters into Agreement with Dermira 12
Galderma Enters into Agreement with ImaBiotech 13
ImaBiotech Enters Into Agreement With Genfit 14
ImaBiotech SAS, Key Competitors 15
ImaBiotech SAS, Key Employees 16
ImaBiotech SAS, Subsidiaries 17

List of Figures
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ImaBiotech SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ImaBiotech SAS, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[ImaBiotech SAS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Neurocrine Biosciences Inc (NBIX):企業の財務・戦略的SWOT分析
    Neurocrine Biosciences Inc (NBIX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Moog Inc (MOG.A):企業の財務・戦略的SWOT分析
    Moog Inc (MOG.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • KEB Hana Bank:企業の戦略・SWOT・財務情報
    KEB Hana Bank - Strategy, SWOT and Corporate Finance Report Summary KEB Hana Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Noront Resources Ltd:企業のM&A・事業提携・投資動向
    Noront Resources Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Noront Resources Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • SAS AB:企業の戦略・SWOT・財務分析
    SAS AB - Strategy, SWOT and Corporate Finance Report Summary SAS AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Groupe Galeries Lafayette:戦略・SWOT・企業財務分析
    Groupe Galeries Lafayette - Strategy, SWOT and Corporate Finance Report Summary Groupe Galeries Lafayette - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Xeltis AG:医療機器:M&Aディール及び事業提携情報
    Summary Xeltis AG (Xeltis) is a clinical-stage medical equipment company that harnesses advances in science to improve the treatment of heart valve related conditions. The company’s polymer-based technology platform, RestoreX, facilitates the natural restoration of heart valve through a process refe …
  • Taiga Building Products Ltd (TBL):企業の財務・戦略的SWOT分析
    Taiga Building Products Ltd (TBL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • PQ Group Holdings Inc (PQG):企業の財務・戦略的SWOT分析
    PQ Group Holdings Inc (PQG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • InTouch Technologies Inc:企業の戦略的SWOT分析
    InTouch Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • The Jim Pattison Group:企業の戦略・SWOT・財務情報
    The Jim Pattison Group - Strategy, SWOT and Corporate Finance Report Summary The Jim Pattison Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • SPX Flow Inc (FLOW):企業の財務・戦略的SWOT分析
    SPX Flow Inc (FLOW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Mediclin AG (MED):企業の財務・戦略的SWOT分析
    Summary Mediclin AG (Mediclin) is a healthcare service provider that provides rehabilitation and medical care services. The center provides services in neuro-medicine with neurology, early neurological rehabilitation, neurosurgery and neuroradiology and psychological sciences, among others. It also …
  • TAP Biosystems Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary TAP Biosystems Ltd (TAP), a subsidiary of Sartorius Stedim Biotech GmbH is a provider of laboratory and pharmaceutical equipment. The company designs and manufactures automated cell culture, bio-reactor systems and fermentation systems. It also provides labware, consumables and accessories. …
  • China Yangtze Power Co Ltd (600900):企業の財務・戦略的SWOT分析
    Summary China Yangtze Power Co Ltd (CYPC) is a renewable energy company that offers power distribution and sale services. The company's services offerings include power distribution covering various areas including consultancy, energy procurement, distribution network construction, energy permit tra …
  • Bata India Limited:企業の戦略・SWOT・財務情報
    Bata India Limited - Strategy, SWOT and Corporate Finance Report Summary Bata India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Ok-Q8 AB:企業の戦略的SWOT分析
    Ok-Q8 AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Hongkong Land Holdings Ltd:企業の戦略・SWOT・財務分析
    Hongkong Land Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Hongkong Land Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • 4D Molecular Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary 4D Molecular Therapeutics Inc (4D Molecular Therapeutics) focuses on the discovery and development of targeted and proprietary AAV gene therapy vectors and therapeutic products. The company developed a discovery platform, Directed Vector Evolution, which empowers to create customized gene de …
  • WGL Holdings, Inc.:企業の戦略・SWOT・財務情報
    WGL Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary WGL Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆